AVOCAT study
Recruiting
- Conditions
- ocally advanced or metastatic carcinoma of the prostate.
- Registration Number
- NL-OMON26811
- Lead Sponsor
- STIWU: Stichting ter bevordering van het Wetenschappelijk Urologisch onderzoek(Foundation for the stimulation of Scientific Urological Research.)
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 324
Inclusion Criteria
1. Patients aged 18 years and above
2. Patients with histologically proven prostate cancer.
Exclusion Criteria
1. Patients simultaneously participating in another study.
2. Previous or concurrent chemotherapy, 5-alpha reductase inhibitor therapy or hormonal therapy specifically for the treatment of prostate cancer other than temporary neo-adjuvant hormonal therapy administered longer than 1 year prior to study entry.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method PSA progression after 3 years of study treatment
- Secondary Outcome Measures
Name Time Method 1. Quality of life<br /><br>2. Performance Status<br /><br>3. Disease progression<br /><br>4. Survival<br /><br>5. Nature and number of Adverse Events<br />